(-)-10,11-Dihydroxyaporphine |
(-)-Apomorphine |
(-)-Apomorphine (hydrochloride) |
(-)-Apomorphine hydrochloride |
(-)-Apomorphinium hydrochloride |
(-)6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol(APO) |
(6aR)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo(de,g)chinolin-10,11-diol |
(6aR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol |
(6aR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol hydrochloride |
(6aR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol;hydrate;hydrochloride |
(9R)-10-methyl-10-azatetracyclo[7.7.1.0^{2,7}.0^{13,17}]heptadeca-1(17),2,4,6,13,15-hexaene-3,4-diol |
(9R)-10-methyl-10-azatetracyclo[7.7.1.0;{2,7}.0;{13,17}]heptadeca-1(16),2(7),3,5,13(17),14-hexaene-3,4-diol |
(Apomorphine) 6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol |
(apomorphine)6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol |
(R)-(-)-Apomorphine |
(R)-(-)-apomorphine HCl |
(R)-(-)-Apomorphine hydrochloride |
(R)-5,6,6A,7-TETRAHYDRO-6-METHYL-4H-DIBENZO[DE-G]QUINOLINE-10,11-DIOL |
(R)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol hydrochloride |
(R)-6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol |
(R)-6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol ((R)-apomorphine) |
(R)-6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol (apomorphine) |
(R)-6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol(apomorphine) |
(R)-Apomorphine |
314-19-2 |
314-19-2 (hydrochloride anhydrous) |
372A207 |
41372-20-7 |
41372-20-7 (hydrochloride hemihydrate) |
4H-Dibenzo(de,g)quinoline-10,11-diol, 5,6,6a,7-tetrahydro-6-methyl-, (R)- |
4H-Dibenzo(de,g)quinoline-10,11-diol, 5,6,6a,7-tetrahydro-6-methyl-, (R)- (9CI) |
4H-Dibenzo(de,g)quinoline-10,11-diol, 5,6,6a,7-tetrahydro-6-methyl-, hydrochloride (1:1), (6aR)- |
4H-Dibenzo(de,g)quinoline-10,11-diol, 5,6,6a,7-tetrahydro-6-methyl-, hydrochloride, (6aR)- |
4H-Dibenzo[de,11-diol, 5,6,6a,7-tetrahydro-6-methyl-, hydrochloride, (R)- |
5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo(de,g)chinolin-10,11-diol hydrochlorid |
58-00-4 |
58-00-4 (Parent) |
5896-07-1 |
6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol ((R)-apomorphine) |
6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol((R)-apomorphine) |
6a-beta-Aporphine-10,11-diol |
6a-beta-Aporphine-10,11-diol, hydrochloride |
6a-beta-Noraporphine-10,11-diol, 6-methyl-, hydrochloride |
6a.beta.-Aporphine-10, hydrochloride |
6a.beta.-Noraporphine-10, 6-methyl-, hydrochloride |
6abeta-Aporphine-10,11-diol |
6abeta-Aporphine-10,11-diol, hydrochloride |
6abeta-Aporphine-10,11-diol, hydrochloride (8CI) |
6abeta-Noraporphine-10,11-diol, 6-methyl-, hydrochloride |
8233AH |
9K13MD7A0D |
AC1L1LLC |
AC1L1SZ7 |
AC1Q3F8P |
AKOS024456928 |
API0001523 |
Apomorfin |
Apomorphin |
Apomorphin hydrochlorid |
apomorphine |
Apomorphine (BAN) |
Apomorphine (intranasal, Parkinson's disease) |
Apomorphine (R,-) |
Apomorphine [BAN] |
Apomorphine chloride |
Apomorphine HCl |
Apomorphine hydrochloride |
Apomorphine Hydrochloride (anhydrous) |
Apomorphine hydrochloride (R,-) |
Apomorphine hydrochloride anhydrous |
Apomorphine hydrochloride hemihydrate |
Apomorphine hydrochloride hydrate |
Apomorphine Hydrochloride, Anhydrous |
Apomorphine SL |
apomorphine-hcl |
APOMORPHINE, HYDROCHLORIDE |
APOMORPHINE6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol |
APOMORPHINEHYDROCHLORIDE |
Apomorphinium chloride |
Apomorphinium chloride hemihydrate |
Apomorphinum hydrochloricum |
Apormorphine |
B6936 |
BB_NC-0484 |
BDBM29644 |
BDBM50001955 |
BG0043 |
Biomol-NT_000019 |
BPBio1_000092 |
BPBio1_001179 |
BRD-K76022557-001-01-3 |
BRD-K76022557-311-20-6 |
BSPBio_000082 |
C17H17NO2 |
C17H17NO2.HCl |
CAS-58-00-4 |
CHEBI:48538 |
CHEMBL1616 |
CHEMBL53 |
cid_6852399 |
CTK8F2000 |
D07460 |
D0B6QP |
D0H6QU |
DB00714 |
DSSTox_CID_2614 |
DSSTox_GSID_22614 |
DSSTox_RID_76660 |
DTXSID5040598 |
DTXSID8022614 |
EINECS 200-360-0 |
EINECS 206-243-0 |
FT-0602881 |
GTPL33 |
H72A207 |
HMS2089C10 |
HSDB 3289 |
IV Apomorphine |
Ixense |
J-018414 |
L-Apomorphine |
LS-21474 |
LS-61218 |
MCULE-1576765478 |
MCULE-3200317958 |
MolPort-003-983-404 |
N-Methylnorapomorphine hydrochloride |
N21FAR7B4S |
NCGC00025349-01 |
NCGC00025349-02 |
NCGC00025349-03 |
NCGC00025349-04 |
NCGC00025349-05 |
NH001 |
NSC 11442 |
NSC-11442 |
NSC11442 |
PDSP1_000780 |
PDSP2_001488 |
pomorphini hydrochloridum |
Prestwick_28 |
Prestwick0_000101 |
Prestwick1_000101 |
Prestwick2_000101 |
Prestwick3_000101 |
Q-200645 |
R-(-)-Apomorphine |
R-(-)-apomorphine HCl |
R-(-)-Apomorphine hydrochloride |
R( C)-10,11- paragraph signthornoC>>u degrees centAEO.E |
R( C)-APO |
SCHEMBL8524 |
SCHEMBL8541 |
SKYZYDSNJIOXRL-BTQNPOSSSA-N |
SMP1_000027 |
SPBio_002021 |
SR-01000597777 |
SR-01000597777-1 |
STOCK1N-03149 |
Tocris-2073 |
Tox21_110967 |
Tox21_110967_1 |
UNII-9K13MD7A0D |
UNII-N21FAR7B4S |
Uprima |
Uprima (TN) |
VMWNQDUVQKEIOC-CYBMUJFWSA-N |
VR-040 |
VR-400 |
VR004 |
WLN: T C6666 1A Q KN & TT & J DQ EQ K1 & GH |
ZINC9073 |